Literature DB >> 33231793

The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database.

Hsiang-Ying Lee1,2, Jia-Hong Tang3, Yen-Hsu Chen2,4,5, Wen-Jeng Wu6, Yung-Shun Juan2, Wei-Ming Li7, Ta-Chien Chan8,9.   

Abstract

PURPOSE: The metabolic syndrome was associated with bladder cancer in the previous studies. However, there have no large-scale cohort studies to elucidate the relationship between metabolic syndromes and urothelial carcinoma including urinary bladder urothelial carcinoma (UBUC) and upper tract urothelial carcinoma (UTUC).
METHODS: We analyze a population-based cohort study by using physical examination data and diagnosis of UC from the Taiwan Cancer Registry Database. Differences in demographic and clinical characteristics among UTUC and non-UTUC groups, UBUC and non-UBUC groups were compared. Odds ratios (ORs) for determining risk factors were estimated through the multiple logistic regression model.
RESULTS: A total of 557,063 records for 211,319 participants which consisted of 31 UTUC and 309 UBUC met the eligibility criteria in this study. Our results showed that female are more likely to develop UTUC than male. As opposed to UTUC, male are more likely to develop UBUC than female. It also showed that participants smoked or chewed betel quid daily are more likely to develop UBUC. Age and estimated glomerular filtration rate (eGFR) are significantly increased the risk of developing UTUC. The association between the eGFR and risk of UTUC is stronger (P < 0.001) for eGFR < 45 (vs. eGFR ≥ 75, OR = 6.795; 95% CI 2.901-15.917). Metabolic syndrome is related to higher risk of UBUC incidence [OR was 1.373 (95% CI 1.104-1.707)].
CONCLUSIONS: There was a significant relationship between the incidence of UBUC and metabolic syndrome. Renal function impairment presents higher risk in both UBUC and UTUC development.

Entities:  

Keywords:  Betel quid; Metabolic syndrome; Renal function; Smoking; Urothelial carcinoma

Year:  2020        PMID: 33231793     DOI: 10.1007/s10147-020-01834-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  3 in total

1.  Areca nut chewing and metabolic syndrome: evidence of a harmful relationship.

Authors:  Kashif Shafique; Mubashir Zafar; Zeeshan Ahmed; Naveed Ali Khan; Muhammad Akbar Mughal; Fauzia Imtiaz
Journal:  Nutr J       Date:  2013-05-20       Impact factor: 3.271

2.  The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China.

Authors:  Sheng Xu; Gui-Ming Zhang; Feng-Ju Guan; Da-Hai Dong; Lei Luo; Bin Li; Xiao-Cheng Ma; Jun Zhao; Li-Jiang Sun
Journal:  World J Surg Oncol       Date:  2015-08-07       Impact factor: 2.754

3.  The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.

Authors:  Nan Sha; Hao Xu; Tao Chen; Da-Wei Tian; Wan-Qin Xie; Lin-Guo Xie; Yu Zhang; Chen Xing; Xiao-Teng Liu; Zhong-Hua Shen; Zhou-Liang Wu; Hai-Long Hu; Chang-Li Wu
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

  3 in total
  2 in total

1.  Could Metabolic Syndrome Be a Predictor of Survival Outcomes in Upper Tract Urothelial Carcinoma? A Propensity Score Matching Study in a Large Chinese Center.

Authors:  Xiang Dai; Fei Wang; Yiqing Du; Caipeng Qin; Shicong Lai; Yuxuan Song; Zixiong Huang; Songchen Han; Xiaopeng Zhang; Tao Xu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 2.  The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis.

Authors:  Lei Peng; Chunyang Meng; Jinze Li; Chengyu You; Yuelin Du; Wei Xiong; Zhongyou Xia; Dehong Cao; Yunxiang Li
Journal:  Eur J Clin Nutr       Date:  2021-11-23       Impact factor: 4.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.